Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
Photodiagnosis Photodyn Ther ; 45: 103952, 2024 Feb.
Article de Anglais | MEDLINE | ID: mdl-38145771

RÉSUMÉ

The rise of antibiotic-resistant bacteria calls for innovative approaches to combat multidrug-resistant strains. Here, the potential of the standard histological stain, Giemsa, to act as a photosensitizer (PS) for antimicrobial photodynamic inactivation (aPDI) against methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA) strains is reported. Bioassays were performed using various Giemsa concentrations (ranging from 0.0 to 20.0 µM) under 625 nm illumination at a light dose of 30 J cm-2. Remarkably, Giemsa completely inhibited the growth of MSSA and MRSA bacterial colonies for concentrations at 10 µM and higher but exhibited no inhibitory effect without light exposure. Partition coefficient analysis revealed Giemsa's affinity for membranes. Furthermore, we quantified the production of reactive oxygen species (ROS) and singlet oxygen (1O2) to elucidate the aPDI mechanisms underlying bacterial inactivation mediated by Giemsa. These findings highlight Giemsa stain's potential as a PS in aPDI for targeting multidrug-resistant bacteria.


Sujet(s)
Anti-infectieux , Staphylococcus aureus résistant à la méticilline , Photothérapie dynamique , Infections à staphylocoques , Humains , Photosensibilisants/pharmacologie , Photosensibilisants/usage thérapeutique , Colorants azurés/pharmacologie , Colorants azurés/usage thérapeutique , Photothérapie dynamique/méthodes , Staphylococcus aureus , Anti-infectieux/usage thérapeutique , Infections à staphylocoques/traitement médicamenteux
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE